Virginia Regulatory Town Hall
Agency
Department of Health Professions
Board
Board of Pharmacy

General Notice
Scheduling of chemicals
Date Posted: 5/2/2017
Expiration Date: 6/13/2017
Submitted to Registrar for publication: YES
41 Day Comment Forum closed. Began on 5/3/2017 and ended 6/13/2017

Pursuant to subsection D of § 54.1-3443, the Board of Pharmacy is giving notice of a public hearing to consider placement of chemical substances in Schedule I of the Drug Control Act.  The public hearing will be conducted at 9:00 a.m. on June 27, 2017 at the Perimeter Center, 9960 Mayland Drive, Suite 201, Richmond, VA 23233.  Public comment may also be submitted electronically or in writing prior to June 13, 2017 to Caroline Juran, Executive Director of the Board of Pharmacy to caroline.juran@dhp.virginia.gov.

 

The Virginia Department of Forensic Science (DFS) has identified three (3) compounds for recommended inclusion into the Code of Virginia. A brief description and chemical name for each compound is as follows:

 The following compound is classified as a research chemical. Compounds of this type have been placed in Schedule I (§ 54.1-3446(3)) in previous legislative sessions.

4-Bromo-2,5-dimethoxy-N-[(2-hydroxyphenyl)methyl]-benzeneethanamine (25B-NBOH), its optical, position, and geometric isomers, salts and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

 The following compound is classified as a cannabimimetic agent. Compounds of this type have been placed in Schedule I (§ 54.1-3446(7)) in previous legislative sessions.

Methyl N-[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]valinate (MMB-CHMICA ), its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

 The following compound is a powerful synthetic opioid. Compounds of this type have been placed in Schedule I (§ 54.1-3446(1)) in previous legislative sessions.

 N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide (Tetrahydrofuran fentanyl), its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation.


Contact Information
Name / Title: Caroline Juran, RPh  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Richmond, 23233
Email Address: caroline.juran@dhp.virginia.gov
Telephone: (804)367-4578    FAX: (804)527-4472    TDD: ()-